Related Experiment Videos
Emotional changes with multiple sclerosis and Parkinson's disease.
S M Rao1, S J Huber, R A Bornstein
1Department of Neurology, Medical College of Wisconsin, Milwaukee 53226.
Journal of Consulting and Clinical Psychology
|June 1, 1992
Summary
Patients with multiple sclerosis (MS) and Parkinson's disease (PD) experience more emotional disorders. This review explores causes and treatment for emotional dysfunction in these chronic neurological conditions.
Area of Science:
- Neurology
- Neuroscience
- Psychiatry
Background:
- Multiple sclerosis (MS) and Parkinson's disease (PD) are common, chronic, progressive neurological disorders affecting subcortical brain structures.
- These conditions often lead to significant physical disability.
- Patients with MS and PD show a higher prevalence of emotional disorders compared to other patient groups with similar physical limitations.
Purpose of the Study:
- To examine methodological challenges in researching emotional disorders in MS and PD.
- To detail the spectrum and severity of emotional dysfunction observed in MS and PD patients.
- To investigate both internal (endogenous) and external (reactive) factors contributing to emotional disorders in these diseases.
Main Methods:
- Literature review focusing on emotional disorders in multiple sclerosis and Parkinson's disease.
- Analysis of methodological issues in existing research.
- Synthesis of findings on the range and severity of emotional dysfunction.
- Examination of etiological theories for emotional disturbances.
Main Results:
- Emotional disorders are more prevalent in MS and PD patients than in comparable patient groups.
- Both endogenous biological changes and reactive psychological responses likely contribute to emotional dysfunction.
- Methodological inconsistencies complicate the interpretation of current research findings.
Conclusions:
- Increased emotional dysfunction is a significant comorbidity in multiple sclerosis and Parkinson's disease.
- Understanding the interplay of endogenous and reactive factors is crucial for effective treatment.
- Further research with improved methodologies is needed to clarify the mechanisms and guide therapeutic interventions.